Is TMS Right for Me?

Solute | TMS Resource Portal

Welcome to TMS Solutions' resource portal, Solute, where you will find the latest informative articles about mental health, neuromodulation techniques, and TMS.

Relevant Posts

Aug 8, 2022 3:19:00 PM

The Effectiveness of rTMS on Persistent Auditory Hallucinations

SOURCE: Psychiatry and Clinical Psychopharmacology. Conference: 9th International
Congress on Psychopharmacology and 5th International Symposium on Child
and Adolescent Psychopharmacology. Antalya Turkey. 27 (Supplement 1) (pp
158-159), 2017.

Read More


Jul 19, 2022 12:29:00 PM

Efficacy of Intensive Bilateral Temporo-Parietal Continuous Theta-Burst Stimulation for Auditory Verbal Hallucinations (TPC-SAVE) in Schizophrenia: A Randomized Sham-Controlled Trial

SOURCE: Asian Journal of Psychiatry. 74:103176, 2022 Aug.

Read More


May 18, 2022 5:17:00 PM

Low-Frequency rTMS Treatment Alters the Topographical Organization of Functional Brain Networks in Schizophrenia Patients with Auditory Verbal Hallucination

SOURCE: Psychiatry Research. 309:114393, 2022 03.

Read More


May 11, 2022 1:33:00 PM

Impact of Low-Frequency rTMS on Functional Connectivity of the Dentate Nucleus Subdomains in Schizophrenia Patients with Auditory Verbal Hallucination

SOURCE: Journal of Psychiatric Research. 149:87-96, 2022 May.

Read More


Feb 6, 2022 5:37:00 PM

Repetitive Transcranial Magnetic Stimulation as a Therapeutic and Probe in Schizophrenia: Examining the Role of Neuroimaging and Future Directions [Review]

Source: Neurotherapeutics. 18(2):827-844, 2021 04.

Authors:
Brandt SJ; Oral HY; Arellano-Bravo C; Plawecki MH; Hummer TA; Francis MM

Abstract:
Schizophrenia is a complex condition associated with perceptual disturbances, decreased motivation and affect, and disrupted cognition. Individuals living with schizophrenia may experience myriad poor outcomes, including impairment in independent living and function as well as decreased life expectancy. Though existing treatments may offer benefit, many individuals still experience treatment resistant and disabling symptoms. In light of the negative outcomes associated with schizophrenia and the limitations in currently available treatments, there is a significant need for novel therapeutic interventions. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique that can modulate the activity of discrete cortical regions, allowing direct manipulation of local brain activation and indirect manipulation of the target's associated neural networks. rTMS has been studied in schizophrenia for the treatment of auditory hallucinations, negative symptoms, and cognitive deficits, with mixed results. The field's inability to arrive at a consensus on the use rTMS in schizophrenia has stemmed from a variety of issues, perhaps most notably
the significant heterogeneity amongst existing trials. In addition, it is likely that factors specific to schizophrenia, rather than the rTMS itself, have presented barriers to the interpretation of existing results. However, advances in approaches to rTMS as a biologic probe and therapeutic, many of which include the integration of neuroimaging with rTMS, offer hope that this technology may still play a role in improving the understanding and treatment of schizophrenia.

Read More


Posts by Topic